Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

36,672 stories, page 169 of 612

Advanced search

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Sichuan Kelun Pharmaceutical : Net profit grew 12.7% to ¥1.13 billion despite a 2.7% revenue decline, aided by one-time gains

TradingViewOriginal source

🌍Aug 26discoverynews.google.comTier 2 · Trade media

Metsera backers establish new biotech armed with China-licensed immunology asset

Pharmaceutical TechnologyOriginal source

🌍Aug 26discoverynews.google.comTier 2 · Trade media

ESC 2026: Common pharma excipient linked to uptick in cardiovascular risk

Pharmaceutical TechnologyOriginal source

🇺🇸Aug 26Industrythefdalawblog.comTier 3 · Secondary coverage

Top Ten Essentials for Preventing Hospital Controlled Substance Diversion

Hyman, Phelps & McNamara (FDA Law)Original source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Ultragenyx Delivers First Gene Therapy FDA Approval for GSDIa

Streetwise ReportsOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Seven drug regulators, including the EU, UK, and Canada, have warned since 2019 that antidepressant-linked sexual side effects can persist for years after the drug is stopped. The US hasn't.

ScienceBlog.comOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

AbbVie Targets Pediatric Alopecia With New Phase 3 Trial: What Investors Should Watch

TipRanksOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Touyun Biotech Group Sees Hk$180 Million-Hk$200 Million Profit And Total Comprehensive Income Attributable For HY2026

TradingViewOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Argenx Just Landed Another Phase 3 Win -- and Wall Street May Be Missing the Bigger Story

The Motley FoolOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Inna Gruber Appointed Senior Director, Global Business Development at Lotus Pharmaceutical

hrtoday.inOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services (WST) Looks 14% Undervalued, Is The Premium Valuation Still Justified?

simplywall.stOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services (WST) Looks 14% Undervalued, Is The Premium Valuation Still Justified?

simplywall.stOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Qlife receives first revenue from pharmaceutical deal

BiostockOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Argenx Just Landed Another Phase 3 Win -- and Wall Street May Be Missing the Bigger Story

AOL.comOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Biotech Growth Trust PLC – LSE:BIOG

TradingViewOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Vivace Therapeutics names new CEO as it prepares Phase 3 trial for mesothelioma drug

Proactive financial newsOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical CDMO Market Size, Report 2026-2035

Global Market Insights Inc.Original source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Hansoh Pharmaceutical Group: Net profit surged 35.8% on double-digit revenue growth and strong innovative medicine sales

TradingViewOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Lady Gaga reveals role at biotech Outer Bio

BioXconomyOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

FDA approves drug to treat HIV infection in newborns

The Pharma LetterOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

FDA advisers narrowly vote to add 6 peptides to a drug compounding list. What's next?

AOL.caOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

JW Pharmaceutical files for Phase 3 trial in Korea of biweekly obesity drug candidate ‘bofanglutide’

더바이오Original source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

HLB Therapeutics completes global Phase 3 trial of NK eye drop candidate ‘RGN-259,’ with topline results expected in November

더바이오Original source

🌍Aug 26discoverynews.google.comTier 2 · Trade media

SK Biopharma pens $795M deal to usher Biohaven’s epilepsy therapy towards hoped-for 2029 launch

Fierce BiotechOriginal source

🇧🇪Aug 26Regulatoryfamhp.beTier 1 · Regulatory source

Actualisering van de lijst van essentiële stoffen voor voedselproducerende paarden

FAMHP BelgiumOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Biotech Stocks At 52-Week Highs - GENB +15%, BDSX +10%, CDNA +6%, CPIX +10%, CRDL +7%

RTTNewsOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

BlackRock Inc. Makes New Investment in Ultragenyx Pharmaceutical Inc. $RARE

MarketBeatOriginal source

🇺🇰Aug 26Regulatorygov.ukTier 1 · Regulatory source

Analysis of the health of Sellafield workers in the National Registry for Radiation Workers (NRRW)

The main aim of the NRRW is to evaluate the impact of radiation exposure on the risks from both canc...

UK Health Security AgencyOriginal source

🇺🇰Aug 26Regulatorygov.ukTier 1 · Regulatory source

NRRW study information: guidance, privacy notice, governance group and publications

The National Registry for Radiation Workers (NRRW) is a long-term follow-up study of the health of r...

UK Health Security AgencyOriginal source

🇺🇰Aug 26Regulatorygov.ukTier 1 · Regulatory source

Guidance on expedited syphilis testing and treatment for inclusion health groups

Guidance for healthcare professionals working in settings and contexts where traditional healthcare...

UK Health Security AgencyOriginal source

🇺🇰Aug 26Regulatorygov.ukTier 1 · Regulatory source

Giardia: national laboratory data

Annual data of reported Giardia infections in England since 2007.

UK Health Security AgencyOriginal source

🇨🇭Aug 26Industryinterpharma.chTier 1 · Company source

Die Schweiz verliert als klinischer Forschungsstandort zunehmend an Bedeutung

Interpharma SwitzerlandOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Australia Pharmaceutical Grade Sodium Carbonate - Market Analysis, Forecast, Size, Trends and Insights

IndexBoxOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

SK Biopharmaceuticals invests 1.1t won, targets US with next-gen epilepsy drug - CHOSUNBIZ

ChosunbizOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Caliway’s CBL-514 Phase 2 Combination Trial Cleared; Phase 3 SUPREME-01 Enrolling

The Clinical Trial VanguardOriginal source

🌍Aug 26Industrymonashhealth.orgTier 1 · Company source

Referring patients with suspected cardiac emergencies to the VHH

Monash HealthOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Algert Global LLC Reduces Position in Ultragenyx Pharmaceutical Inc. $RARE

MarketBeatOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

FDA Approval for Slimming Teas Weight Loss: What It Really Means and How to Use It Safely bh4jSeiMO

Villa de la OrotavaOriginal source

🌍Aug 26Industrymonashhealth.orgTier 1 · Company source

Increased-risk aneuploidy screening results: referral changes

Monash HealthOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Enwei Pharmaceutical Co., Ltd. Class A – SZSE:301331

TradingViewOriginal source

🇫🇮Aug 26Researchhelsinki.fiTier 2 · Direct publisher

Olkapään rakenteellisia muutoksia löytyy lähes kaikilta yli 40-vuotiailta

Helsinki University ResearchOriginal source

🇯🇵Aug 26Industrysumitomo-pharma.comTier 1 · Company source

Sumitomo Pharma Selected as a Constituent of the JPX Prime 150 Index

Sumitomo PharmaOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Consun Pharmaceutical Group: Revenue and profit surged, gross margin improved, and an interim dividend was declared

TradingViewOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

MPSC Cancels Drug Inspector Recruitment Over Sweeping Paper Leak Scandal

streamlinefeed.co.keOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

SK Biopharm strikes $800m deal for epilepsy drug from Biohaven

The Korea HeraldOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Pharmosa Biopharm's Partner Liquidia Ramps Up L606 Clinical Investment; Second-Half R&D Spending to Double

finance.biggo.comOriginal source

🌍Aug 26discoverynews.google.comTier 2 · Trade media

Inside the Gulf biotech deal model, ahead of RGMBS 2026 in Riyadh

BioSpaceOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Wildland firefighters warned not to take supplements for smoke or PFAS exposure

wildfiretoday.comOriginal source

🌍Aug 26Industrymonashhealth.orgTier 1 · Company source

Early Pregnancy Bleeding Clinic: now accepting eReferrals only

Monash HealthOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Tivicay: US FDA Approves Drug to Treat HIV In Newborns

Health and MeOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Zhejiang CONBA Pharmaceutical Co., Ltd. Class A – SSE:600572

TradingViewOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

In Five Years, Will K-Pharma and Biotech Cross the 'Fortune 500' Threshold?

포춘코리아Original source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Ayub's at Fort in Mumbai loses food licence after FDA action

Time Out WorldwideOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

U.S. badly trails China in lowering barriers to biotech innovation

Genetic Literacy ProjectOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Chinese Biotech Stocks Rally as Local Firms Advance Cancer Vaccines - News and Statistics

IndexBoxOriginal source

🇺🇸Aug 26Regulatoryfda.govTier 1 · Regulatory source

Baxter Issues Voluntary Nationwide Recall for Two Lots of 0.9% Sodium Chloride Injection Due to Potential Presence of Particulate Matter

FOR IMMEDIATE RELEASE – AUG. 25, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is vol...

FDA MedWatchOriginal source

🇺🇸Aug 26Regulatoryfda.govTier 1 · Regulatory source

Percutaneous Catheter Recall: Boston Scientific Removes ENROUTE Transcarotid Neuroprotection System

ENROUTE Transcarotid Neuroprotection Systems may have arterial sheath tip separation or partial tip...

FDA MedWatchOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Flies, open drains, dirty kitchen: Popular Mumbai eatery Ayub's loses licence

India TodayOriginal source

🌍Aug 26discoverynews.google.comTier 3 · Aggregated media

Daiko Pharmaceutical has applied to change its market segment to the Tokyo Stock Exchange Standard Market.

MoomooOriginal source

🌍Aug 26discoverynews.google.comTier 2 · Trade media

Emerging Biomarkers Shaping The Next Generation of Oncology Drug Development

Fierce BiotechOriginal source

Pharmaceutical industry news

Sichuan Kelun Pharmaceutical : Net profit grew 12.7% to ¥1.13 billion despite a 2.7% revenue decline, aided by one-time gains

Metsera backers establish new biotech armed with China-licensed immunology asset

ESC 2026: Common pharma excipient linked to uptick in cardiovascular risk

Top Ten Essentials for Preventing Hospital Controlled Substance Diversion

Ultragenyx Delivers First Gene Therapy FDA Approval for GSDIa

Seven drug regulators, including the EU, UK, and Canada, have warned since 2019 that antidepressant-linked sexual side effects can persist for years after the drug is stopped. The US hasn't.

AbbVie Targets Pediatric Alopecia With New Phase 3 Trial: What Investors Should Watch

Touyun Biotech Group Sees Hk$180 Million-Hk$200 Million Profit And Total Comprehensive Income Attributable For HY2026

Argenx Just Landed Another Phase 3 Win -- and Wall Street May Be Missing the Bigger Story

Inna Gruber Appointed Senior Director, Global Business Development at Lotus Pharmaceutical

West Pharmaceutical Services (WST) Looks 14% Undervalued, Is The Premium Valuation Still Justified?

West Pharmaceutical Services (WST) Looks 14% Undervalued, Is The Premium Valuation Still Justified?

Qlife receives first revenue from pharmaceutical deal

Argenx Just Landed Another Phase 3 Win -- and Wall Street May Be Missing the Bigger Story

Enterprise value to revenue forward of Biotech Growth Trust PLC – LSE:BIOG

Vivace Therapeutics names new CEO as it prepares Phase 3 trial for mesothelioma drug

Pharmaceutical CDMO Market Size, Report 2026-2035

Hansoh Pharmaceutical Group: Net profit surged 35.8% on double-digit revenue growth and strong innovative medicine sales

Lady Gaga reveals role at biotech Outer Bio

FDA approves drug to treat HIV infection in newborns

FDA advisers narrowly vote to add 6 peptides to a drug compounding list. What's next?

﻿﻿﻿JW Pharmaceutical files for Phase 3 trial in Korea of biweekly obesity drug candidate ‘bofanglutide’

﻿﻿HLB Therapeutics completes global Phase 3 trial of NK eye drop candidate ‘RGN-259,’ with topline results expected in November

SK Biopharma pens $795M deal to usher Biohaven’s epilepsy therapy towards hoped-for 2029 launch

Actualisering van de lijst van essentiële stoffen voor voedselproducerende paarden

Biotech Stocks At 52-Week Highs - GENB +15%, BDSX +10%, CDNA +6%, CPIX +10%, CRDL +7%

BlackRock Inc. Makes New Investment in Ultragenyx Pharmaceutical Inc. $RARE

Analysis of the health of Sellafield workers in the National Registry for Radiation Workers (NRRW)

NRRW study information: guidance, privacy notice, governance group and publications

Guidance on expedited syphilis testing and treatment for inclusion health groups

Giardia: national laboratory data

Die Schweiz verliert als klinischer Forschungsstandort zunehmend an Bedeutung

Australia Pharmaceutical Grade Sodium Carbonate - Market Analysis, Forecast, Size, Trends and Insights

SK Biopharmaceuticals invests 1.1t won, targets US with next-gen epilepsy drug - CHOSUNBIZ

Caliway’s CBL-514 Phase 2 Combination Trial Cleared; Phase 3 SUPREME-01 Enrolling

Referring patients with suspected cardiac emergencies to the VHH

Algert Global LLC Reduces Position in Ultragenyx Pharmaceutical Inc. $RARE

FDA Approval for Slimming Teas Weight Loss: What It Really Means and How to Use It Safely *bh4jSeiMO*

Increased-risk aneuploidy screening results: referral changes

Enterprise value to EBIT forward of Enwei Pharmaceutical Co., Ltd. Class A – SZSE:301331

Olkapään rakenteellisia muutoksia löytyy lähes kaikilta yli 40-vuotiailta

Sumitomo Pharma Selected as a Constituent of the JPX Prime 150 Index

Consun Pharmaceutical Group: Revenue and profit surged, gross margin improved, and an interim dividend was declared

MPSC Cancels Drug Inspector Recruitment Over Sweeping Paper Leak Scandal

SK Biopharm strikes $800m deal for epilepsy drug from Biohaven

Pharmosa Biopharm's Partner Liquidia Ramps Up L606 Clinical Investment; Second-Half R&D Spending to Double

Inside the Gulf biotech deal model, ahead of RGMBS 2026 in Riyadh

Wildland firefighters warned not to take supplements for smoke or PFAS exposure

Early Pregnancy Bleeding Clinic: now accepting eReferrals only

Tivicay: US FDA Approves Drug to Treat HIV In Newborns

Enterprise value to revenue forward of Zhejiang CONBA Pharmaceutical Co., Ltd. Class A – SSE:600572

In Five Years, Will K-Pharma and Biotech Cross the 'Fortune 500' Threshold?

Ayub's at Fort in Mumbai loses food licence after FDA action

U.S. badly trails China in lowering barriers to biotech innovation

Chinese Biotech Stocks Rally as Local Firms Advance Cancer Vaccines - News and Statistics

Baxter Issues Voluntary Nationwide Recall for Two Lots of 0.9% Sodium Chloride Injection Due to Potential Presence of Particulate Matter

Percutaneous Catheter Recall: Boston Scientific Removes ENROUTE Transcarotid Neuroprotection System

Flies, open drains, dirty kitchen: Popular Mumbai eatery Ayub's loses licence

Daiko Pharmaceutical has applied to change its market segment to the Tokyo Stock Exchange Standard Market.

Emerging Biomarkers Shaping The Next Generation of Oncology Drug Development

JW Pharmaceutical files for Phase 3 trial in Korea of biweekly obesity drug candidate ‘bofanglutide’

HLB Therapeutics completes global Phase 3 trial of NK eye drop candidate ‘RGN-259,’ with topline results expected in November

FDA Approval for Slimming Teas Weight Loss: What It Really Means and How to Use It Safely bh4jSeiMO